Spots Global Cancer Trial Database for combined modality therapy
Every month we try and update this database with for combined modality therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer | NCT00001499 | Carcinoma, Non-... Lung Neoplasms | paclitaxel cisplatin chest radiother... | - | National Institutes of Health Clinical Center (CC) | |
| Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum | NCT00346099 | Rectal Cancer Neoplasm Metast... | Panitumumab wit... Panitumumab wit... | 18 Years - | NSABP Foundation Inc | |
| RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus | NCT00559351 | Esophageal Neop... Squamous Cell C... | transthoracic e... neoadjuvant che... neoadjuvant che... | 18 Years - 75 Years | Ministry of Scientific Research and Information Technology, Poland | |
| A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC | NCT00144989 | Small-Cell-Lung... | Etoposide and c... Irinotecan and ... | 20 Years - 70 Years | Japan Clinical Oncology Group | |
| Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma | NCT00000801 | Lymphoma, Non-H... HIV Infections | Filgrastim Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Cytarabine Dexamethasone | 16 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) | NCT00502112 | Myelodysplastic... | lintuzumab lenalidomide | 18 Years - | Seagen Inc. | |
| Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer | NCT05262452 | Pancreatic Canc... Chemotherapy Ef... Ultrasound Ther... | ALPIUS 900, an ... FOLFIRINOX regi... | 19 Years - 85 Years | Seoul National University Hospital | |
| Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members | NCT00000703 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Zidovudine Dexamethasone | 19 Years - 69 Years | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCL | NCT00655837 | Lymphoma, Large... Lymphoma, Non-H... | SGN-40 rituximab gemcitabine | 18 Years - | Seagen Inc. | |
| Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma | NCT00000801 | Lymphoma, Non-H... HIV Infections | Filgrastim Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Cytarabine Dexamethasone | 16 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members | NCT00000703 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Zidovudine Dexamethasone | 19 Years - 69 Years | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study | NCT01419145 | Cancer Cachexia | Multimodal inte... Standard care | 18 Years - 80 Years | Norwegian University of Science and Technology | |
| Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma | NCT00000801 | Lymphoma, Non-H... HIV Infections | Filgrastim Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Cytarabine Dexamethasone | 16 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Evaluation of Vertebroplasty Associated With Radiotherapy for Spine Metastases (EVAR) | NCT00267033 | Osseous Spine M... | injection of or... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Concurrent Chemoradiotherapy With Docetaxel and Cisplatin in Esophageal Cancer | NCT01640860 | Esophageal Canc... | 18 Years - 75 Years | Chonnam National University Hospital | ||
| Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum | NCT00346099 | Rectal Cancer Neoplasm Metast... | Panitumumab wit... Panitumumab wit... | 18 Years - | NSABP Foundation Inc | |
| The Intrathecal Morphine for Nephrectomy | NCT01997788 | Renal Cell Carc... | The intrathecal... The intravenous... Demerol on dema... | 18 Years - 80 Years | Seoul National University Hospital | |
| A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL | NCT00529503 | Lymphoma, Large... Lymphoma, Non-H... | SGN-40 placebo rituximab etoposide carboplatin ifosfamide | 18 Years - 75 Years | Seagen Inc. | |
| Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma | NCT00525447 | Multiple Myelom... | SGN-40 lenalidomide dexamethasone | 18 Years - | Seagen Inc. | |
| The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer | NCT01787539 | Gastric Cancer | Postoperative C... | 18 Years - | Medical University of Lublin | |
| RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus | NCT00559351 | Esophageal Neop... Squamous Cell C... | transthoracic e... neoadjuvant che... neoadjuvant che... | 18 Years - 75 Years | Ministry of Scientific Research and Information Technology, Poland | |
| A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies | NCT00649584 | Disease, Hodgki... Lymphoma, Large... Lymphoma, Non-H... | SGN-35 gemcitabine | 12 Years - | Seagen Inc. | |
| A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL | NCT00529503 | Lymphoma, Large... Lymphoma, Non-H... | SGN-40 placebo rituximab etoposide carboplatin ifosfamide | 18 Years - 75 Years | Seagen Inc. | |
| Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer | NCT00001499 | Carcinoma, Non-... Lung Neoplasms | paclitaxel cisplatin chest radiother... | - | National Institutes of Health Clinical Center (CC) | |
| A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC | NCT00144989 | Small-Cell-Lung... | Etoposide and c... Irinotecan and ... | 20 Years - 70 Years | Japan Clinical Oncology Group | |
| The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer | NCT00000723 | Lymphoma, Non-H... HIV Infections | Methotrexate Leucovorin calc... Zidovudine Dexamethasone | 18 Years - 70 Years | National Institute of Allergy and Infectious Diseases (NIAID) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
